|
TRIP12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.12059999963266E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.19480000004835E-07 |
| Normal-vs-Stage2 |
1.926250E-02 |
| Normal-vs-Stage3 |
2.485800E-02 |
| Normal-vs-Stage4 |
1.539610E-01 |
| Stage1-vs-Stage2 |
4.603600E-01 |
| Stage1-vs-Stage3 |
2.086600E-01 |
| Stage1-vs-Stage4 |
5.102200E-01 |
| Stage2-vs-Stage3 |
7.719000E-01 |
| Stage2-vs-Stage4 |
9.284200E-01 |
| Stage3-vs-Stage4 |
8.966800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.63990000035375E-07 |
| Normal-vs-AfricanAmerican |
6.15219999999805E-05 |
| Normal-vs-Asian |
9.967600E-02 |
| Caucasian-vs-AfricanAmerican |
9.623600E-01 |
| Caucasian-vs-Asian |
6.467200E-01 |
| AfricanAmerican-vs-Asian |
6.405400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.25020005038135E-09 |
| Normal-vs-Female |
1.643800E-01 |
| Male-vs-Female |
3.966600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.998600E-04 |
| Normal-vs-Extreme_Weight |
5.44429945570357E-10 |
| Normal-vs-Obese |
1.835180E-03 |
| Normal-vs-Extreme_Obese |
3.079500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.605600E-02 |
| Normal_Weight-vs-Obese |
4.540600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.042000E-01 |
| Extreme_Weight-vs-Obese |
3.295300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.837600E-01 |
| Obese-vs-Extreme_Obese |
4.800600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.348200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.85749999999896E-05 |
| Normal-vs-Age(61-80Yrs) |
5.20409999538174E-08 |
| Normal-vs-Age(81-100Yrs) |
9.08460000004219E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.052200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.437700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.630070E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.323700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.452250E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.950200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.28460000414776E-08 |
| Normal-VS-Type2 PRCC |
8.10290000000657E-05 |
| Normal-VS-KIRP CIMP |
1.931970E-01 |
| Normal-VS-Unclassified PRCC |
1.118760E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.491400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.963200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.234400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.361500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.938220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.435700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70299999990853E-07 |
| Normal-vs-N1 |
6.381200E-01 |
| Normal-vs-N2 |
2.603800E-01 |
| N0-vs-N1 |
6.777100E-03 |
| N0-vs-N2 |
2.192600E-01 |
| N1-vs-N2 |
6.889600E-01 |
|
|
